122 related articles for article (PubMed ID: 3757151)
21. Synergism of the polyamine analogue, N1,N11-bisethylnorspermine with cis-diaminedichloroplatinum (II) against murine neoplastic cell lines in vitro and in vivo.
Hawthorne TR; Austin JK
Cancer Lett; 1996 Jan; 99(1):99-107. PubMed ID: 8564936
[TBL] [Abstract][Full Text] [Related]
22. Cisplatin combined with the new cisplatin-procaine complex DPR: in vitro and in vivo studies.
Viale M; Vannozzi MO; Merlo F; Cafaggi S; Parodi B; Esposito M
Eur J Cancer; 1996 Dec; 32A(13):2327-33. PubMed ID: 9038617
[TBL] [Abstract][Full Text] [Related]
23. The significance of DNA cross-linking to cis-diamminedichloroplatinum(II)-induced cytotoxicity in sensitive and resistant lines of murine leukemia L1210 cells.
Strandberg MC; Bresnick E; Eastman A
Chem Biol Interact; 1982 Mar; 39(2):169-80. PubMed ID: 7199396
[TBL] [Abstract][Full Text] [Related]
24. [Systemic chemotherapy with super-high dose cisplatin and sodium thiosulfate (STS) rescue in mice].
Lee K; Sawamura M; Kubota T; Ishibashi N; Kawamura E
Gan To Kagaku Ryoho; 1985 Apr; 12(4):875-9. PubMed ID: 4039124
[TBL] [Abstract][Full Text] [Related]
25. Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection.
Howell SB; Pfeifle CE; Wung WE; Olshen RA
Cancer Res; 1983 Mar; 43(3):1426-31. PubMed ID: 6681730
[TBL] [Abstract][Full Text] [Related]
26. Protection by sodium thiosulfate and thiourea against lethal toxicity of cis-diamminedichloroplatinum (II) in bacteria and mice.
Ishizawa M; Taniguchi S; Baba T
Jpn J Pharmacol; 1981 Dec; 31(6):883-9. PubMed ID: 6801366
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxicity and cellular accumulation of a new cis-diammineplatinum (II) complex containing procaine in murine L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II).
Viale M; Cafaggi S; Parodi B; Esposito M
Cancer Chemother Pharmacol; 1995; 35(5):371-6. PubMed ID: 7850917
[TBL] [Abstract][Full Text] [Related]
28. DNA synthesis, protein synthesis and platinum content following drug administration in cis-diamminedichloroplatinum(II) -sensitive and -resistant L1210 cells transferred from in vitro to in vivo conditions.
Hanusovská E; Ujházy V
Neoplasma; 1987; 34(6):721-6. PubMed ID: 3431611
[TBL] [Abstract][Full Text] [Related]
29. [Experimental combination chemotherapy of YNK01, a novel analog of cytarabine, with other antitumor agents].
Uchida T; Nagahata T; Arakawa M; Ekimoto H; Takahashi K
Gan To Kagaku Ryoho; 1990 Jul; 17(7):1351-6. PubMed ID: 2114829
[TBL] [Abstract][Full Text] [Related]
30. Potentiation of cisplatin antitumor activity on L1210 leukemia s.c. by sparsomycin and three of its analogues.
Zylicz Z; Hofs HP; Wagener DJ
Cancer Lett; 1989 Jul; 46(2):153-7. PubMed ID: 2752385
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of synergism of drugs cis-diamminedichloroplatinum (II) and arabinosylcytosine on the level of chemical interaction with DNA and on the growth of mouse leukemia.
Rauko P; Novotný L; Reichelová V; Balázová E
Gen Pharmacol; 1991; 22(5):805-10. PubMed ID: 1761184
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of in vivo antitumor activity of classical anticancer agents by combination with the new, glutathione-interacting DNA minor groove-binder, brostallicin.
Sabatino MA; Colombo T; Geroni C; Marchini S; Broggini M
Clin Cancer Res; 2003 Nov; 9(14):5402-8. PubMed ID: 14614026
[TBL] [Abstract][Full Text] [Related]
33. Preclinical antitumor activity of ethyldeshydroxysparsomycin in combination with cisplatin.
Hofs HP; Wagener DJ; De Valk-Bakker V; Van Rennes H; De Vos D; Doesburg WH; Ottenheijm HC; De Grip WJ
Invest New Drugs; 1995; 13(1):23-32. PubMed ID: 7499104
[TBL] [Abstract][Full Text] [Related]
34. Studies on the resistance of a murine leukemia L1210 cell line cis-diamminedichloroplatinum (II).
Eastman A; Bresnick E
Biochem Pharmacol; 1981 Oct; 30(19):2721-3. PubMed ID: 7197523
[No Abstract] [Full Text] [Related]
35. High-dose cisplatin with sodium thiosulfate protection.
Pfeifle CE; Howell SB; Felthouse RD; Woliver TB; Andrews PA; Markman M; Murphy MP
J Clin Oncol; 1985 Feb; 3(2):237-44. PubMed ID: 4038510
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
[TBL] [Abstract][Full Text] [Related]
37. Combined antitumor effect of cyclophosphamide and bromodeoxyuridine in BDF1 mice bearing L1210 ascites tumors.
Kagawa Y; Noge I; Higashigawa M; Komada Y
Biol Pharm Bull; 2008 Jan; 31(1):57-61. PubMed ID: 18175942
[TBL] [Abstract][Full Text] [Related]
38. Systemic chemotherapy in tumor-bearing rats using high-dose cis-diamminedichloroplatinum(II) with low nephrotoxicity in combination with angiotensin II and sodium thiosulfate.
Kobayashi H; Hasuda K; Aoki K; Taniguchi S; Baba T
Int J Cancer; 1990 May; 45(5):940-4. PubMed ID: 2335397
[TBL] [Abstract][Full Text] [Related]
39. [Two-route chemotherapy using the anticancer drug cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate].
Kuroiwa T; Baba T
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1011-7. PubMed ID: 3566300
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151).
Woodman RJ
Cancer Chemother Rep 2; 1974 Mar; 4(1):45-52. PubMed ID: 4826499
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
